A carregar...
Effectiveness and safety of poly (ADP-ribose) polymerase inhibitors in cancer therapy: A systematic review and meta-analysis
Poly (ADP-ribose) polymerase (PARP) inhibitors are a class of small-molecule drugs suppressing PARP enzymes activity, inducing the death of cells deficient in homologous recombination repair (HRR). HRR deficiency is common in tumor cells with BRCA gene mutation. Since their first clinical trial in 2...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884943/ https://ncbi.nlm.nih.gov/pubmed/26399274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.5367 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|